Results 121 to 130 of about 84,926 (204)

Erratum to: Influence of nonsteroidal anti-inflammatory drugs on aspirin’s antiplatelet effects and suggestion of the most suitable time for administration of both agents without resulting in interaction [PDF]

, 2017
Kenta Shibata, Yuuki Akagi, Naofumi Nozawa, Hitoshi Shimomura, Takao Aoyama   +4 more
openalex   +1 more source

Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI

, 2023
Raffaele Piccolo, Paolo Calabrò, Attilio Varricchio, Cesare Baldi, Giovanni Napolitano, Ciro De Simone, Ciro Mauro, Eugenio Stabile, Gianluca Caiazzo, Tullio Tesorio, Marco Boccalatte, Bernardino Tuccillo, G Bottiglieri, Enrico Russolillo, Emilio Di Lorenzo, Greta Carrara, Salvatore Cassese, Sergio Leonardi, Simone Biscaglia, Francesco Costa, Eugène McFadden, Dik Heg, Anna Franzone, Giulio Stefanini, Davide Capodanno, Giovanni Esposito   +25 more
openalex   +1 more source

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta-analysis. [PDF]

J Thromb Thrombolysis, 2021
Kow CS, Hasan SS.
europepmc   +1 more source

Frequency of analgesic drugs use and patients' awareness of their possible interactions with antiplatelet therapy in coronary heart disease

, 2017
Izabela Pałasz, Łukasz Reczek, Martyna Schönborn, Sebastian Janiec, Małgorzata Cebeńko   +4 more
openalex   +1 more source

Impact of anticoagulation and antiplatelet drugs on surgery rates and mortality in trauma patients. [PDF]

Sci Rep, 2021
Bläsius FM, Laubach M, Andruszkow H, Lübke C, Lichte P, Lefering R, Hildebrand F, Horst K.   +7 more
europepmc   +1 more source

Associations Between Industry Payments to Physicians for Antiplatelet Drugs and Utilization of Cardiac Procedures and Stents. [PDF]

J Gen Intern Med, 2022
Yanagisawa M, Blumenthal DM, Kato H, Inoue K, Tsugawa Y.   +4 more
europepmc   +1 more source

Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?

Терапевтический архив, 2011
Antiplatelet drugs are essential in current treatment of coronary heart disease (CHD) but they have an adverse action - damage to gastrointestinal mucosa.
Oksana Mikhaylovna Drapkina, Ol'ga Nikolaevna Korneeva, O M Drapkina, O N Korneeva   +3 more
doaj  

Vascular Endothelial Repair and the Influence of Circulating Antiplatelet Drugs in a Carotid Coil Model. [PDF]

J Cent Nerv Syst Dis, 2021
Fukawa N, Ueda T, Ogoshi T, Kitazawa Y, Takahashi J.   +4 more
europepmc   +1 more source

Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety. [PDF]

Evid Based Complement Alternat Med, 2021
Yu Z, Li X, Zhang X, Li D, Gu Y, Wu M, Wu M, Liu L.   +7 more
europepmc   +1 more source

Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug‐eluting stent implantation: importance of social factors in Asian patients

, 2009
C‐L. Poh, Mark Y. Chan, Clara Bik‐San Lau, S‐G. Teo, Adrian F. Low, HC Tan, Chi‐Hang Lee   +6 more
openalex   +2 more sources